XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current Assets    
Cash $ 3,727 $ 250,234
Due from government agency 1,099 1,060
Prepaid expenses and deposits (Note 7) 22,504 56,627
Deferred financing costs (Note 5) 12,641   
Assets, Current, Total 39,971 307,921
Deferred financing costs (Note 5) 20,768 32,291
Assets, Total 60,739 340,212
Current Liabilities    
Accounts payable and accrued liabilities 1,327,984 794,291
Research agreement obligations (Note 3) 365,970 259,752
Derivative liability – warrants (Note 4) 871,858 1,317,834
Derivative liability – conversion option (Note 4) 200,700   
Convertible notes payable (Note 5) 1,184,351 998,790
Loans payable (Note 6) 28,000 7,000
Promissory note (Note 7) 167,942 100,000
Due to related parties (Note 8) 281,475 322,905
Liabilities, Current, Total 4,428,280 3,800,572
Capital stock (Note 9)    
Common stock, $0.001 par value, 150,000,000 shares authorized 73,861,754 shares issued and outstanding (2011 – 52,073,460) 73,864 52,072
Additional paid-in capital 43,220,515 39,943,374
Shares and warrants to be issued 242,062 362,906
Deferred compensation (Note 9)    (35,968)
Deficit accumulated during the development stage (47,840,900) (43,722,216)
Accumulated other comprehensive loss (63,082) (60,528)
Stockholders' Equity Attributable to Parent, Total (4,367,541) (3,460,360)
Liabilities and Equity, Total $ 60,739 $ 340,212